A Quick Look at Today's Ratings for SPS Commerce(SPSC.US), With a Forecast Between $225 to $230
Analysts' Top Healthcare Picks: Inozyme Pharma (INZY), Glaukos (GKOS)
SPS Commerce Price Target Raised to $230.00/Share From $210.00 by Craig-Hallum
SPS Commerce (SPSC) Receives a Buy From D.A. Davidson
Loop Capital Maintains SPS Commerce(SPSC.US) With Buy Rating, Raises Target Price to $230
Stifel Maintains SPS Commerce(SPSC.US) With Buy Rating, Raises Target Price to $225
Truist Financial Maintains Robert Half(RHI.US) With Hold Rating, Announces Target Price $62
Truist Financial Maintains Ensign(ENSG.US) With Hold Rating
Truist Financial Keeps Their Hold Rating on The Ensign Group (ENSG)
William Blair Maintains SPS Commerce(SPSC.US) With Hold Rating
Analysts Conflicted on These Technology Names: Tyler Technologies (TYL) and SPS Commerce (SPSC)
SPS Commerce Analyst Ratings
Barclays Sticks to Their Sell Rating for Robert Half (RHI)
Robert Half (RHI) Gets a Hold From J.P. Morgan
J.P. Morgan Maintains Robert Half(RHI.US) With Hold Rating, Cuts Target Price to $70
Robert Half Price Target Cut to $70.00/Share From $74.00 by JP Morgan
Robert Half Analyst Ratings
Truist Adjusts Price Target on Robert Half International to $62 From $72, Maintains Hold Rating
Truist Financial Maintains Robert Half(RHI.US) With Hold Rating
Goldman Sachs Maintains Robert Half(RHI.US) With Sell Rating, Cuts Target Price to $55